Anu Connor

VP, Head of Oncology External Innovation at IPSEN

Speaker

Anu Connor is Vice President, Head of Oncology External Innovation at Ipsen. In her current role, Anu and her team work closely with scientific, clinical, and commercial functions to identify and evaluate external opportunities in oncology, both in solid tumors and hematologic malignancies, that are a strategic fit for Ipsen’s portfolio. Prior to her role at Ipsen, Anu led the Hematology Search and Evaluation Business Development team at BMS. Prior to BMS, Anu led Due Diligence, Search and Evaluation activities across therapeutic areas in the NIBR BD&L organization at Novartis. Prior to her transition to search and evaluation, Anu had roles in the toxicology/translational medicine organizations at Genentech/Roche and Novartis.